6555 results
Cited 27 times since 2011 (2 per year)
source: EuropePMC
BMC medical genetics,
Volume 12, 6 1 2011, Pages 131
Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses.
Trompet S, de Craen AJ, Postmus I, Ford I, Sattar N, Caslake M, Stott DJ, Buckley BM, Sacks F, Devlin JJ, Slagboom PE, Westendorp RG, Jukema JW, PROSPER Study Group
Background: The PHArmacogenetic study of Statins in the Elderly at risk (PHASE) is a genome wide association study in the PROspective Study of Pravastatin in the Elderly at risk for vascular disease (PROSPER) that investigates the genetic variation responsible for the individual variation in drug response to pravastatin. Statins lower LDL-cholesterol in general by 30%, however not in all subjects. Moreover, clinical response is highly variable and adverse effects occur in a minority of patients....
Abstract
Cited 28 times since 2011 (2.1 per year)
source: EuropePMC
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
Volume 14, Issue 4, 4 1 2011, Pages 522-527
Long-term outcome of ablative therapy of post-operative atrial tachyarrhythmias in patients with tetralogy of Fallot: a European multi-centre study.
de Groot NM, Lukac P, Schalij MJ, Makowski K, Szili-Torok T, Jordaens L, Nielsen JC, Jensen HK, Gerdes JC, Delacretaz E
Aim: Post-operative atrial tachyarrhythmias (AT) in patients with tetralogy of Fallot (ToF) are associated with congestive heart failure, stroke, and cardiac death. Effective treatment is therefore essential. The aim of the study is to evaluate long-term outcome of ablative therapy of AT in ToF patients and to study characteristics of AT recurrences. Methods and results: Tetralogy of Fallot patients (N = 38, age 43 ± 12 years) referred for ablation of post-operative AT, appearing 26 ± 10 years a...
Abstract
Cited 1 times since 2011 (0.1 per year)
source: EuropePMC
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 19, Issue 10, 1 1 2011, Pages 440-441
Paroxysmal mechanical aortic valve prosthesis dysfunction: capturing the right moment.
Sorgdrager BJ, Tavilla G, van der Wall EE, Scholte AJ
Abstract
Cited 1 times since 2011 (0.1 per year)
source: EuropePMC
Current pharmaceutical design,
Volume 17, Issue 30, 1 1 2011, Pages 3308-3327
Cell therapy for the treatment of chronic ischemic heart disease.
Rodrigo SF, Ramshorst Jv, Beeres SL, Bax JJ, Schalij MJ, Atsma DE
Over the last decade, much was learned about the biology of several types of stem and progenitor cells. It has become apparent that various cell sources may have the capacity to promote cardiomyogenesis and new blood vessel formation through different mechanisms, forming the rationale for cell-based therapy in patients with chronic ischemic heart disease. After initial clinical studies have provided evidence for safety of cell administration, larger randomized trials demonstrated variable effect...
Abstract
Cited 5 times since 2011 (0.4 per year)
source: EuropePMC
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 19, Issue 10, 1 1 2011, Pages 432-435
Per-operative stent placement in the right pulmonary artery; a hybrid technique for the management of pulmonary artery branch stenosis at the time of pulmonary valve replacement in adult Fallot patients.
Windhausen F, Boekholdt SM, Bouma BJ, Groenink M, Backx AP, de Winter RJ, Mulder BJ, Hazekamp MG, Koolbergen DR
After having undergone surgical correction at an early age, many patients with tetralogy of Fallot develop long-term complications including progressive pulmonary regurgitation and peripheral pulmonary stenosis. A high percentage of these patients need to undergo a second operation in their adolescence or early adulthood. If simultaneous treatment of both pulmonary regurgitation and peripheral pulmonary stenosis is warranted, a complete surgical approach has several disadvantages. We describe fo...
Abstract
The international journal of cardiovascular imaging,
Volume 27, Issue 7, 1 1 2011, Pages 989-993
CMR-determined scar volume: predictive for ventricular tachycardias?
van der Wall EE, Zeppenfeld K, Bax JJ, Siebelink HM, Schalij MJ
Abstract
Cited 15 times since 2011 (1.1 per year)
source: EuropePMC
Heart (British Cardiac Society),
Volume 97, Issue 20, 1 1 2011, Pages 1704-1714
Multimodality imaging before, during, and after percutaneous mitral valve repair.
Delgado V, Kapadia S, Marsan NA, Schalij MJ, Tuzcu EM, Bax JJ
Abstract
Cited 21 times since 2011 (1.6 per year)
source: EuropePMC
Archives of orthopaedic and trauma surgery,
Volume 132, Issue 2, 30 5 2011, Pages 257-263
Determinants of outcome in operatively and non-operatively treated Weber-B ankle fractures.
Van Schie-Van der Weert EM, Van Lieshout EM, De Vries MR, Van der Elst M, Schepers T
Introduction: Treatment of ankle fractures is often based on fracture type and surgeon's individual judgment. Literature concerning the treatment options and outcome are dated and frequently contradicting. The aim of this study was to determine the clinical and functional outcome after AO-Weber B-type ankle fractures in operatively and conservatively treated patients and to determine which factors influenced outcome. Patients and methods: A retrospective cohort study in patients with a AO-W...
Abstract
Cited 49 times since 2011 (3.6 per year)
source: EuropePMC
Ageing research reviews,
Volume 11, Issue 1, 29 5 2011, Pages 67-77
A systematic review of 'knowledge of dementia' outcome measures.
Spector A, Orrell M, Schepers A, Shanahan N
Knowledge of dementia measures are key to identifying areas of misinformation and establishing knowledge levels, thus guiding educational programmes and interventions. A three-step literature search was undertaken to identify measures of knowledge in dementia. An evaluation framework was employed articulating quality indicators for the psychometric properties of measures, based on their development and use within research studies. Five measures were identified: the Alzheimer's Disease Knowl...
Abstract
Cited 27 times since 2011 (2 per year)
source: EuropePMC
American journal of physiology. Lung cellular and molecular physiology,
Volume 302, Issue 1, 23 4 2011, Pages L56-67
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP, Walther FJ, Walther FJ, Laghmani el H, Steendijk P, Middeldorp M, van der Laarse A, Wagenaar GT
Phosphodiesterase (PDE) 4 inhibitors are potent anti-inflammatory drugs with antihypertensive properties, and their therapeutic role in bronchopulmonary dysplasia (BPD) is still controversial. We studied the role of PDE4 inhibition with piclamilast on normal lung development and its therapeutic value on pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) in neonatal rats with hyperoxia-induced lung injury, a valuable model for premature infants with severe BPD. The cardiopulmonar...
Abstract
Cited 2 times since 2011 (0.1 per year)
source: EuropePMC
Revista espanola de cardiologia,
Volume 64, Issue 11, 22 4 2011, Pages 1035-1044
[Three-dimensional imaging in cardiac resynchronization therapy].
Auger D, Schalij MJ, Bax JJ, Delgado V
Cardiac resynchronization therapy improves clinical symptoms and prognosis of heart failure patients. However, it has been shown that up to 40% of patients do not respond to this therapy. Three main determinants of cardiac resynchronization therapy response have been identified: left ventricular dyssynchrony, left ventricular lead position, and extent and location of myocardial scar tissue. Two-dimensional echocardiography is the first imaging technique to evaluate patients who may be candidates...
Abstract
Cited 21 times since 2011 (1.6 per year)
source: EuropePMC
Atherosclerosis,
Volume 220, Issue 2, 21 3 2011, Pages 413-417
Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J, Packard C, Buckley BM, Schaefer EJ
Our goal was to determine whether genetic variation at genes affecting statin metabolism or targets of statin therapy would influence low density lipoprotein (LDL) cholesterol lowering with pravastatin, baseline heart disease, or cardiac endpoints on trial. We examined associations of single nucleotide polymorphisms (SNPs) at the liver X receptor alpha (LXRA, rs12221497), and the solute carrier organic anion transporter (SLCO1B1, rs4149056 and rs2306283) gene loci with these variables. We studie...
Abstract
Cited 65 times since 2011 (4.8 per year)
source: EuropePMC
The breast journal,
Volume 17, Issue 6, 21 3 2011, Pages 661-668
Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases.
Akbulut S, Yilmaz D, Bakir S
This study aimed to discuss the role of agents, such as steroids and methotrexate (MTX), in the treatment of patients with idiopathic granulomatous mastitis (IGM). Using Pubmed and Google Scholar data bases, a retrospective study was carried out on IGM cases treated with steroids and/or MTX between 1972 and 2010. Four IGM cases treated with MTX at our clinic were also summarized in this study. A total of 541 IGM cases since 1972, including ours, were retrospectively analyzed. Steroid treatment 5...
Abstract
Cited 23 times since 2011 (1.7 per year)
source: EuropePMC
Blood,
Volume 118, Issue 20, 21 3 2011, Pages 5613-5621
High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.
Noordermeer SM, Sanders MA, Gilissen C, Tönnissen E, van der Heijden A, Döhner K, Bullinger L, Jansen JH, Valk PJ, van der Reijden BA
Aberrations in protein ubiquitination have recently been identified in the pathogenesis of acute myeloid leukemia (AML). We studied whether expression changes of more than 1600 ubiquitination related genes correlated with clinical outcome in 525 adult AML patients. High expression of one of these genes, BRE, was observed in 3% of the cases and predicted favorable prognosis independently of known prognostic factors (5-year overall survival: 57%). Remarkably, unsupervised expression profiling show...
Abstract
Cited 16 times since 2011 (1.2 per year)
source: EuropePMC
Heart (British Cardiac Society),
Volume 98, Issue 3, 13 2 2011, Pages 232-237
Age- and gender-specific differences in the prognostic value of CT coronary angiography.
Yiu KH, de Graaf FR, Schuijf JD, van Werkhoven JM, Marsan NA, Veltman CE, de Roos A, Pazhenkottil A, Kroft LJ, Boersma E, Herzog B, Leung M, Maffei E, Leung DY, Kaufmann PA, Cademartiri F, Bax JJ, Jukema JW
Objective: To evaluate the potential age- and gender-specific differences in the incidence and prognostic value of coronary artery disease (CAD) in patients undergoing CT coronary angiography (CTA). Design and patients: In this multicentre prospective registry study, 2432 patients (mean age 57 ± 12, 56% male) underwent CTA for suspected CAD. Patients were stratified into four groups according to age
Abstract
Cited 158 times since 2011 (11.7 per year)
source: EuropePMC
Nature reviews. Cardiology,
Volume 9, Issue 1, 13 2 2011, Pages 53-62
Restenosis after PCI. Part 1: pathophysiology and risk factors.
Jukema JW, Verschuren JJ, Ahmed TA, Quax PH
Restenosis is a complex disease for which the pathophysiological mechanisms have not yet been fully elucidated, but are thought to include inflammation, proliferation, and matrix remodeling. Over the years, many predictive clinical, biological, (epi)genetic, lesion-related, and procedural risk factors for restenosis have been identified. These factors are not only useful in risk stratification of patients, they also contribute to our understanding of this condition. Furthermore, these factors pr...
Abstract
Cited 23 times since 2011 (1.7 per year)
source: EuropePMC
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
Volume 14, Issue 1, 13 2 2011, Pages 66-73
Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.
van Rees JB, Borleffs CJ, Thijssen J, de Bie MK, van Erven L, Cannegieter SC, Bax JJ, Schalij MJ
Aims: In elderly patients, obscurity remains regarding the benefit of implantable cardioverter-defibrillator (ICD) treatment as primary prevention of sudden cardiac death. This study assesses implant rates, therapy, adverse events, and survival gain in the elderly primary prevention ICD patient. Methods and results: A total of 1395 patients treated with an ICD for primary prevention of sudden cardiac death at the Leiden University Medical Center were included and allocated to three groups accord...
Abstract
Cited 11 times since 2011 (0.8 per year)
source: EuropePMC
Journal of cardiovascular electrophysiology,
Volume 23, Issue 1, 13 2 2011, Pages 74-80
Toward magnetic resonance-guided electroanatomical voltage mapping for catheter ablation of scar-related ventricular tachycardia: a comparison of registration methods.
Tao Q, Milles J, VAN Huls VAN Taxis C, Lamb HJ, Reiber JH, Zeppenfeld K, VAN DER Geest RJ
Introduction: Integration of preprocedural delayed enhanced magnetic resonance imaging (DE-MRI) with electroanatomical voltage mapping (EAVM) may provide additional high-resolution substrate information for catheter ablation of scar-related ventricular tachycardias (VT). Accurate and fast image integration of DE-MRI with EAVM is desirable for MR-guided ablation. Methods and results: Twenty-six VT patients with large transmural scar underwent catheter ablation and preprocedural DE-MRI. With diffe...
Abstract
Cited 300 times since 2011 (22.2 per year)
source: EuropePMC
Nature genetics,
Volume 43, Issue 10, 11 2 2011, Pages 1005-1011
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, Bochud M, Rice KM, Henneman P, Smith AV, Ehret GB, Amin N, Larson MG, Mooser V, Hadley D, Dörr M, Bis JC, Aspelund T, Esko T, Janssens AC, Zhao JH, Heath S, Laan M, Fu J, Pistis G, Luan J, Arora P, Lucas G, Pirastu N, Pichler I, Jackson AU, Webster RJ, Zhang F, Peden JF, Schmidt H, Tanaka T, Campbell H, Igl W, Milaneschi Y, Hottenga JJ, Vitart V, Chasman DI, Trompet S, Bragg-Gresham JL, Alizadeh BZ, Chambers JC, Guo X, Lehtimäki T, Kühnel B, Lopez LM, Polašek O, Boban M, Nelson CP, Morrison AC, Pihur V, Ganesh SK, Hofman A, Kundu S, Mattace-Raso FU, Rivadeneira F, Sijbrands EJ, Uitterlinden AG, Hwang SJ, Vasan RS, Wang TJ, Bergmann S, Vollenweider P, Waeber G, Laitinen J, Pouta A, Zitting P, McArdle WL, Kroemer HK, Völker U, Völzke H, Glazer NL, Taylor KD, Harris TB, Alavere H, Haller T, Keis A, Tammesoo ML, Aulchenko Y, Barroso I, Khaw KT, Galan P, Hercberg S, Lathrop M, Eyheramendy S, Org E, Org E, Sõber S, Lu X, Nolte IM, Penninx BW, Corre T,
Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans. We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 × 10(-8) to P = 2.3 × 10(-13)) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31...
Abstract
Cited 51 times since 2011 (3.8 per year)
source: EuropePMC
PloS one,
Volume 6, Issue 9, 9 2 2011, Pages e24164
Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts.
Ramkisoensing AA, Pijnappels DA, Askar SF, Passier R, Swildens J, Goumans MJ, Schutte CI, de Vries AA, Scherjon S, Mummery CL, Schalij MJ, Atsma DE
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this study, differentiation of human (h) MSCs derived from embryonic, fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle cells was investigated. Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbilical cord, bone marrow, amniotic membrane and adult bone marrow and adipose tissue were co-cultured with neonatal rat cardiomyocytes (nrCMCs) or cardiac fibroblasts...
Abstract
